New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 24, 2013
11:50 EDTEXELExelixis announces availability of COMETRIQ in the U.S.
Exelixis announced the commercial availability of COMETRIQ for the treatment of patients with progressive, metastatic medullary thyroid cancer. The U.S. FDA approved COMETRIQ on November 29, 2012. COMETRIQ is being distributed exclusively through Diplomat Specialty Pharmacy in the U.S.
News For EXEL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 24, 2015
16:55 EDTEXELExelixis provides 2015 outlook
Subscribe for More Information
16:54 EDTEXELExelixis reports Q4 EPS (30c), consensus (30c)
Reports Q4 revenue $7.4M, consensus $7.8M.
February 19, 2015
10:32 EDTEXELHigh option volume stocks:
Subscribe for More Information
09:12 EDTEXELOn The Fly: Pre-market Movers
Subscribe for More Information
05:31 EDTEXELExelixis announces acceptance of NDA for Genentech cobimetinib
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use